D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents

• Status: Completed
• Trial end date: 2012-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to show whether D-cycloserine in combination with cognitive behavioral therapy (CBT) is more effective than CBT plus placebo to reduce symptoms of posttraumatic stress disorder (PTSD) in 13-18 year-old children.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tulane University School of Medicine
• Collaborator: National Alliance for Research on Schizophrenia and Depression
• Treatments: Cycloserine

Criteria

Inclusion Criteria:

• Certain number of PTSD symptoms plus functional impairment

• Must be able to swallow pills

Exclusion Criteria:

• Serious kidney or liver disease

• Epilepsy

• Bipolar disorder

• Psychosis